On 2 October 2026, SANVO Fine Chemicals Group Limited announced the appointment of Mr. Jian Ziqing, aged 56, as an Independent Non-Executive Director (INED) and member of four key board committees—Audit, Remuneration, Nomination and Environmental, Social & Governance—effective immediately.
Mr. Jian brings over three decades of medical technology and R&D experience, including senior positions at Sanofi Winthrop Pharmaceuticals (1997-2008) and subsequent general manager roles at Zhongshan-based medical technology companies. He holds a bachelor’s degree in Pharmacology from China Pharmaceutical University.
The company has signed a three-year letter of appointment with Mr. Jian. Annual remuneration is set at RMB0.24 million, determined by the board in line with his responsibilities, market benchmarks and the Remuneration Committee’s recommendation. In accordance with Hong Kong Listing Rules, Mr. Jian will be subject to retirement by rotation and re-election at the company’s annual general meetings.
Mr. Jian has confirmed compliance with all independence criteria under Rules 3.13(1)-(8) of the Listing Rules and reported no financial, professional or familial ties with the Group, its subsidiaries, or connected persons. He also holds no shares in SANVO Fine Chemicals and has not served on other listed company boards in the past three years.
Following this appointment, SANVO Fine Chemicals’ board now comprises: • Executive Directors: Mr. Chen Bingqiang (Chairman & CEO) and Mr. Ng Cheuk Lun • Non-Executive Director: Ms. Wang Xiaorong • Independent Non-Executive Directors: Ir. Daniel Lai, Mr. Xu Kai, Mr. Yeung Chun Yue David and Mr. Jian Ziqing
The board extended a formal welcome to Mr. Jian upon his induction.
Comments